Fredphone, each given every 12 hours for 7 days. Pain intensity, nausea, and sedation erick, Pickering, Ontario, Canada. were assessed by patients four times daily, and breakthrough analgesia was recorded. ## RESULTS. Thirty-one patients completed the study (18 women, 13 men; mean age, 56 { 3 ye
β¦ LIBER β¦
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain
β Scribed by Helen Hays; Neil Hagen; Michael Thirlwell; H. Dhaliwal; Najib Babul; Zoltan Harsanyi; Andrew C. Darke
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 933 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Comparative clinical efficacy and safety
β
Neil A. Hagen; Najib Babul
π
Article
π
1997
π
John Wiley and Sons
π
English
β 210 KB
π 2 views
Comparison of the efficacy, safety, and
β
Eduardo D. Bruera; Tara J. Maceachern; Kathy. Spachynski; Donald F. Legatt; R. N
π
Article
π
1994
π
John Wiley and Sons
π
English
β 803 KB
Clinical efficacy, safety and pharmacoki
β
F. Moolenaar; W. J. Meijler; H. W. Frijlink; J. Visser; J. H. Proost
π
Article
π
2000
π
Springer
π
English
β 113 KB
Controlled-release morphine tablets in p
β
Carol A. Warfield
π
Article
π
1998
π
John Wiley and Sons
π
English
β 143 KB
π 2 views
## Background: Controlled-release (cr) morphine tablets have become routine therapy in the management of cancer pain. compared with immediate-release (ir) morphine, this formulation provides the benefit of dosing every 12 hours. ## Methods: This study reviewed the 10 published, well controlled, r
Critical review of oral drug treatments
β
Hugo Adriaensen; LΓ©on Plaghki; Chantal Mathieu; Alfred Joffroy; Kris Vissers
π
Article
π
2005
π
John Wiley and Sons
π
English
β 132 KB